TGen MemVerge Hopes 'Big Memory Computing' Will Accelerate Bioinformatics Data Processing Premium The Silicon Valley startup recently announced deals with Penn State, TGen, and Analytical Biosciences to cut computational time and improve data recovery. Jumpcode Genomics, TGen Partner to Test Metagenomic Approaches for COVID Detection The company and institute are collaborating on the development of a diagnostic assay that uses Jumpcode's CRISPR-based reagents and TGen's NGS technology. TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test Premium As diagnostics firms develop a new wave of COVID-19 tests using next-gen sequencing, TGen researchers are also adding CRISPR-based sample prep to their kit. TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine Premium The liquid biopsy method analyzes fragment ends within recurrently protected regions in cell-free DNA from a patient's urine sample. Sequencing-Based Tuberculosis Drug Resistance Testing Gaining Momentum Premium The WHO and FIND are supporting NGS-based testing in low-resource settings, while a resistance testing program at New York State's Wadsworth Center has matured. Sep 15, 2020 Pancreatic Cancer Treatment Clues Uncovered From Genomic, Chromatin Profiles Aug 9, 2019 TGen-Led Team Prepares to Validate 'TARDIS' Blood-Based Cancer Monitoring Method Premium Apr 15, 2019 Genetic Technologies, TGen to Launch Genetic Tests in US Mar 18, 2019 TGen Inks Tuberculosis Test Deal With Advanced Biological Laboratories Mar 15, 2019 TGen Adjusting to New Realities of Bioinformatics for Precision Medicine Premium Dec 14, 2018 In Brief This Week: Cancer Research UK, NeoGenomics, Luminex, and More Sep 26, 2018 TGen, University of New Mexico Win $2.8M NIH Grant to Study Diabetic Blindness Sep 13, 2018 TGen Team Hopes $2M Study Will Help Lay Path for Liquid Biopsy Monitoring in Metastatic Melanoma Premium Aug 31, 2018 TGen Wins $2M NIH Grant for Blood-Based Melanoma Monitoring Approach Aug 29, 2018 Poultry-Adapted E. Coli Implicated in Subset of Urinary Tract Infections Dec 20, 2017 BSWRI, TGen Partner to Develop Multi-Marker Panel for Early Pancreatic Cancer Detection Premium Jun 6, 2017 Hereditary Cancer Panel Study Suggests Germline Mutations Missed in Some Pancreatic Cancers May 4, 2017 Genomic Data Yields New Insights Into Breast Cancer Mortality Gap Between Black, White Women May 2, 2017 Critical Path Institute, TGen Partner on Tuberculosis Sequencing Project Mar 8, 2017 TGen LymeSeq Assay Moving Forward With Financial Backing From Advocacy Group Premium Nov 30, 2016 City of Hope, Translational Genomics Research Institute Form Personalized Medicine Alliance Nov 23, 2016 TGen Receives $200K Nvidia Foundation Award Sep 27, 2016 Anthrax Genome From Autopsy Samples Offers Insights Into 1970s Soviet Biowarfare Program Mar 10, 2016 Dell Expands Clinical Archive With an Eye Towards Merging Medical Images With Genomics Premium Nov 19, 2015 Eyeing Clinical Sequencing Market, Dell Upgrades Hardware Package for Genomic Analysis Premium Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Time to Sit Back and Relax NPR reports that the US National Institutes of Health has transferred the last of its eligible, former research chimpanzees to a sanctuary. Omicron-Focused Vaccines The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant. Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more. Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.